Biodextris Inc., a subsidiary of Clean Biologics SAS, announced the development of a new industrial-scale vaccine and biologics development, manufacturing and packaging plant. The new facility will support companies in the development and characterization of next-generation biological products and will help bridge the gap between research projects and large-scale commercial production. The center will begin operations in the summer of 2023, and the company expects to add about 15 specializ...